Abstract Library

#2145 Thrombotic Risk in Gastroenteropancreatic Neuroendocrine Tumors: A Single Centre Experience

Introduction: Neuroendocrine neoplasms (NENs) comprise a heterogeneous group of neoplasms associated with paraneoplastic syndromes. Venous thromboembolism (VTE) is a frequent complication in neoplastic patients and it is associated with increased morbidity and mortality. To date, there have been no specific studies in NEN, except for glucagon-secreting tumors

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Cavalcoli F

Authors: Cavalcoli F, Rossi R, Artoni A, Sciola V, Zilli A,

Keywords: GEP-NEt, paraneoplastic syndromes, Venous thromboembolism,

#11 Plasma chromogranin - A response to octreotide test: Prognostic value for clinical outcome in endocrine digestive tumors

Introduction: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) expressing somatostatin receptors may be treated with somatostatin analogues (SSAs). Selection criteria are a positive Octreoscan® or a >50% hormone level decrease after octreotide s.c. injection (octreotide test) (OT). Plasma chromogranin A (CgA) is the best general GEP-NET marker, but data on CgA response to OT are scant.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author: Massironi S

Authors: Massironi S, Conte D, Sciola V, Spampatti M, Rossi R,

Keywords: gastroenteropancreatic neuroendocrine tumors, carcinoids, pancreatic endocrine tumors, chromogranin A, somatostatin analogues,